Skip to main content

Cytosorbents Corp

CTSO
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001175151

In the last 90 days, Cytosorbents Corp insiders filed 4 open-market purchases and 0 sales; 50 institutions reported holding it in 13F filings for Q2 2026, worth $6.04M in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding Cytosorbents Corp changed between Q4 2024 and Q1 2025.

All holders in Q1 2025All holders in Q4 2024

13F holders of CTSO: Q4 2024 compared with Q1 2025
MeasureQ4 2024Q1 2025Change
Holders5149−2
Shares15.3M16.9M+1.61M (+10.5%)
Value$14.1M$16.9M+$2.81M (+19.9%)

New holders (7)

Institutions that held Cytosorbents Corp at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to CTSO in Q1 2025
InstitutionSharesValue% of portfolio
NWF Advisory Services Inc.104,139$104.1K0.01%
Gsa Capital Partners LLP53,030$53.0K0.00%
Squarepoint Ops LLC40,549$40.5K0.00%
Two Sigma Securities, LLC15,287$15.3K0.00%
Citadel Advisors LLC8,183$8.18K0.00%
N.E.W. Advisory Services LLC2,720$2.72K0.00%
Lazard Asset Management LLC954$00.00%

Sold out (9)

Institutions that held Cytosorbents Corp at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of CTSO in Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Engineers Gate Manager LP52,751$48.0K
Cable Car Capital LLC50,000$45.5K
Millennium Management LLC33,280$30.3K
Resources Investment Advisors, LLC.15,000$13.7K
Johnson Investment Counsel Inc11,534$10.5K
HRT Financial LP11,509$10.0K
Jane Street Group, LLC10,147$9.23K
New Wave Wealth Advisors LLC1,631$1.48K
Simplex Trading, LLC313$0